10-QPeriod: Q2 FY2004

BIOGEN INC. Quarterly Report for Q2 Ended Jun 30, 2004

Filed August 9, 2004For Securities:BIIB

Summary

Biogen Idec Inc.'s Form 10-Q for the quarterly period ended June 30, 2004, indicates a company actively navigating its operations post-merger, as evidenced by its status as an accelerated filer. The unaudited financial statements for the three and six months ended June 30, 2004, along with the accompanying Management's Discussion and Analysis, provide crucial insights into the company's financial health and operational performance during this period. Investors should pay close attention to the revenue trends, profitability, and cash flow generation as detailed in the condensed consolidated statements. While the filing doesn't provide specific period-over-period financial figures here, it lays the groundwork for understanding the company's progress in integrating its businesses and executing its strategic objectives. The inclusion of legal proceedings and changes in securities details in Part II also warrants investor review for any potential impacts on the company's value and operations.

Key Highlights

  • 1Biogen Idec Inc. is filing its quarterly report for the period ending June 30, 2004, as required by Section 13 or 15(d) of the Securities Exchange Act.
  • 2The company has maintained its status as an accelerated filer, suggesting a significant market capitalization and adherence to regular reporting standards.
  • 3Key financial information includes unaudited Condensed Consolidated Statements of Income, Balance Sheets, and Cash Flows for the relevant periods.
  • 4Management's Discussion and Analysis of Financial Condition and Results of Operations is provided, offering insights into operational performance and financial standing.
  • 5The filing includes sections on Legal Proceedings, Changes in Securities, Use of Proceeds, Issuer Purchases, and Submission of Matters to Vote of Security Holders, which are important for a comprehensive understanding of the company's current situation.
  • 6Several exhibits are listed, including amendments to the 1998 Stock Plan and Severance Policy, indicating ongoing corporate governance and employee incentive adjustments.

Frequently Asked Questions

This Form 10-Q is a quarterly report that provides an update on Biogen Idec Inc.'s financial performance and significant business activities for the period ended June 30, 2004. It includes unaudited financial statements and management's discussion on the company's condition and results of operations.

Yes, the company is identified as an 'accelerated filer,' which is a designation for companies that meet certain reporting requirements, typically indicating a substantial public float and market capitalization.

The report contains unaudited Condensed Consolidated Statements of Income for the three and six months ended June 30, 2004 and 2003, Condensed Consolidated Balance Sheets as of June 30, 2004 and December 31, 2003, and Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2004 and 2003.

Investors can refer to Item 2, 'Management’s Discussion and Analysis of Financial Condition and Results of Operations,' for a more in-depth explanation and commentary from the company's management regarding its financial performance and outlook.